Most recently, it has been determined that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar places as classical opioid receptors, it binds to a wide array of endogenous opioids. Contrary to most opioid receptors, this receptor acts like a scavenger https://geraldc319zbc0.losblogos.com/profile